February 15, 2026
Vertex Announces Reimbursement for ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) in Australia, a new once-daily next-in-class Treatment for People with Cystic Fibrosis
Center-left
The National Tribune
Owner:
The National Tribune Australia